Endologix CEO and leadership

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

Matt Thompson is a Chief Medical Officer at Endologix Inc; Independent Board Member at Vivos Therapeutics; and Staff Surgeon, Department of Vascular Surgery, Heart and Vascular Institute, CCF, Ohio, USA at Cleveland Clinic and is based in Cleveland, Ohio. He has worked as Professor Of Surgery at St George's, University of London (for students and alumni). Matt studied at University of Leicester between 1991 and 1993, Stanford Graduate School of Business between 2019 and 2020, and Queen Mary University of London between 1984 and 1987.

Cindy Pinto is an Interim Chief Financial Officer at Endologix Inc and is based in North Haven, Connecticut. She has worked as Finance Manager at STARBUCKS CORP, Finance Manager at Covidien (Medtronic Minimally Invasive Therapies Group), and Division Finance Manager at Nestle Waters. Cindy studied at Stern School Of Business and Villanova University.

Jeffrey Brown is a Chief Operating Officer at Endologix Inc. He works or has worked at STERIS and works or has worked as General Manager at Boston Scientific and General Manager at Johnson & Johnson. Jeffrey studied at Babson College and University of New Hampshire.

Matt Thompson is a Chief Medical Officer at Endologix Inc; Independent Board Member at Vivos Therapeutics; and Staff Surgeon, Department of Vascular Surgery, Heart and Vascular Institute, CCF, Ohio, USA at Cleveland Clinic and is based in Cleveland, Ohio. He has worked as Professor Of Surgery at St George's, University of London (for students and alumni). Matt studied at University of Leicester between 1991 and 1993, Stanford Graduate School of Business between 2019 and 2020, and Queen Mary University of London between 1984 and 1987.

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

Matt Thompson is a Chief Medical Officer at Endologix Inc; Independent Board Member at Vivos Therapeutics; and Staff Surgeon, Department of Vascular Surgery, Heart and Vascular Institute, CCF, Ohio, USA at Cleveland Clinic and is based in Cleveland, Ohio. He has worked as Professor Of Surgery at St George's, University of London (for students and alumni). Matt studied at University of Leicester between 1991 and 1993, Stanford Graduate School of Business between 2019 and 2020, and Queen Mary University of London between 1984 and 1987.